FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jay Rappaport

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Physiology

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jay Rappaport
In fond remembrance and tribute to Dr. Kuan-Teh Jeang, M.D., Ph.D.
Michael Kogan; Satish L Deshmane; Edward J Gracely; Kamel Khalili; Bassel E Sawaya; Jay Rappaport
Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.
Michael Kogan; Gabrielle Lehmicke; Tracy Fischer-Smith; Rafal Kaminsky; Jay Rappaport
CSF-1R up-regulation is associated with response to pharmacotherapy targeting tyrosine kinase activity in AML cell lines.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jay Rappaport (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jay Rappaport
In fond remembrance and tribute to Dr. Kuan-Teh Jeang, M.D., Ph.D.
Journal of neurovirology 2013;19(2):117-8.
2013: Michael Kogan; Satish L Deshmane; Edward J Gracely; Kamel Khalili; Bassel E Sawaya; Jay Rappaport
Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.
Journal of cellular physiology 2013;228(4):781-90.
2012: Michael Kogan; Gabrielle Lehmicke; Tracy Fischer-Smith; Rafal Kaminsky; Jay Rappaport
CSF-1R up-regulation is associated with response to pharmacotherapy targeting tyrosine kinase activity in AML cell lines.
Anticancer research 2012;32(3):893-9.
2012: Michael Kogan; Tracy Fischer-Smith; Valerie Haine; Yuxong Ke; Brian Wigdahl; Jay Rappaport
Macrophage colony stimulating factor regulation by nuclear factor kappa B: a relevant pathway in human immunodeficiency virus type 1 infected macrophages.
DNA and cell biology 2012;31(3):280-9.
2011: Jeffrey Maranto; Jay Rappaport; Prasun K Datta
Role of C/EBP-β, p38 MAPK, and MKK6 in IL-1β-mediated C3 gene regulation in astrocytes.
Journal of cellular biochemistry 2011;112(4):1168-75.
2010: Inna Rom; Armine Darbinyan; Martyn K White; Jay Rappaport; Bassel E Sawaya; Shohreh Amini; Kamel Khalili
Activation of HIV-1 LTR by Rad51 in microglial cells.
Cell cycle (Georgetown, Tex.) 2010;9(18):3715-22.
2009: Satish L Deshmane; Ruma Mukerjee; Shongshan Fan; Luis Del Valle; Carine Michiels; Thersa Sweet; Inna Rom; Kamel Khalili; Jay Rappaport; Shohreh Amini; Bassel E Sawaya
Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression.
The Journal of biological chemistry 2009;284(17):11364-73.
2008: Tracy Fischer-Smith; Christie Bell; Sidney Croul; Mark Lewis; Jay Rappaport
Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies.
Journal of neurovirology 2008;14(4):318-26.
2008: Huichen Wang; Martyn K White; Rafal Kaminski; Nune Darbinian; Shohreh Amini; Edward M Johnson; Kamel Khalili; Jay Rappaport
Role of Puralpha in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat.
Anticancer research 2008;28(3A):1441-7.
2008: Tracy Fischer-Smith; Ellen M Tedaldi; Jay Rappaport
CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.
AIDS research and human retroviruses 2008;24(3):417-21.
2008: Jeffrey Maranto; Jay Rappaport; Prasun K Datta
Regulation of complement component C3 in astrocytes by IL-1beta and morphine.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2008;3(1):43-51.
2008: Rafal Kaminski; Nune Darbinian; Bassel E Sawaya; Dorota Slonina; Shohreh Amini; Edward M Johnson; Jay Rappaport; Kamel Khalili; Armine Darbinyan
Puralpha as a cellular co-factor of Rev/RRE-mediated expression of HIV-1 intron-containing mRNA.
Journal of cellular biochemistry 2008;103(4):1231-45.
2007: Yvonne M Mueller; Constantinos Petrovas; Duc H Do; Susan R Altork; Tracy Fischer-Smith; Jay Rappaport; John D Altman; Mark G Lewis; Peter D Katsikis
Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects.
Journal of virology 2007;81(20):10861-8.
2007: Huichen Wang; Meijuan Wang; Krzysztof Reiss; Nune Darbinian-Sarkissian; Edward M Johnson; George Iliakis; Shohreh Amini; Kamel Khalili; Jay Rappaport
Evidence for the involvement of Puralpha in response to DNA replication stress.
Cancer biology & therapy 2007;6(4):596-602.
2006: Prasun K Datta; Jay Rappaport
HIV and complement: hijacking an immune defense.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2006;60(9):561-8.
2006: Dorota Kaniowska; Rafal Kaminski; Shohreh Amini; Sujatha Radhakrishnan; Jay Rappaport; Edward Johnson; Kamel Khalili; Luis Del Valle; Armine Darbinyan
Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.
Journal of virology 2006;80(18):9288-99.
2006: Nune Darbinian-Sarkissian; Marta Czernik; Francesca Peruzzi; Jennifer Gordon; Jay Rappaport; Krzysztof Reiss; Kamel Khalili; Shohreh Amini
Dysregulation of NGF-signaling and Egr-1 expression by Tat in neuronal cell culture.
Journal of cellular physiology 2006;208(3):506-15.
2006: Valerie Haine; Tracy Fischer-Smith; Jay Rappaport
Macrophage colony-stimulating factor in the pathogenesis of HIV infection: potential target for therapeutic intervention.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2006;1(1):32-40.
2006: Nune Darbinian-Sarkissian; Armine Darbinyan; Jessica Otte; Sujatha Radhakrishnan; Bassel E Sawaya; A Arzumanyan; Galina Chipitsyna; Y Popov; Jay Rappaport; Shohreh Amini; Kamel Khalili
p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome.
Gene therapy 2006;13(4):288-95.
2005: Tracy Fischer-Smith; Jay Rappaport
Evolving paradigms in the pathogenesis of HIV-1-associated dementia.
Expert reviews in molecular medicine 2005;7(27):1-26.
2005: Francesca Peruzzi; Valeria Bergonzini; Susanna Aprea; Krzysztof Reiss; Bassel E Sawaya; Jay Rappaport; Shohreh Amini; Kamel Khalili
Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: implication for HIV-associated dementia.
Brain research. Brain research reviews 2005;50(1):114-25.
2005: Gora Diop; Jean-Louis Spadoni; Hervé Do; Thomas Hirtzig; Cédric Coulonges; Taoufik labib; Wolfgang J Issing; Jay Rappaport; Amu Therwath; Mark Lathrop; Fumihiko MATSUDA; Jean-François Zagury
Genomic approach of AIDS pathogenesis: exhaustive genotyping of the TNFR1 gene in a French AIDS cohort.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2005;59(8):474-80.
2005: Emmanuel G Régulier; Reshma Panemangalore; Max W Richardson; Jeremy J DeFranco; Virginia Kocieda; Devon C Gordon-Lyles; Peter Silvera; Kamel Khalili; Jean-François Zagury; Mark G Lewis; Jay Rappaport
Persistent anti-gag, -Nef, and -Rev IgM levels as markers of the impaired functions of CD4+ T-helper lymphocytes during SIVmac251 infection of cynomolgus macaques.
Journal of acquired immune deficiency syndromes (1999) 2005;40(1):1-11.
2005: Sebastien Bertin-Maghit; Christelle Capini; Natacha Bessis; Jacques Chomilier; Sylviane Muller; Aïcha Abbas; Ludovic Autin; Jean-Louis Spadoni; Jay Rappaport; Amu Therwath; Marie-Christophe Boissier; Jean-François Zagury
Improvement of collagen-induced arthritis by active immunization against murine IL-1beta peptides designed by molecular modelling.
Vaccine 2005;23(33):4228-35.
2005: Selvajothi Abraham; Thersa Sweet; Bassel E Sawaya; Jay Rappaport; Kamel Khalili; Shohreh Amini
Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes.
Journal of neuroimmunology 2005;160(1-2):219-27.
2005: Hervé Do; Alexandre Vasilescu; Gora Diop; Thomas Hirtzig; Simon Heath; Cédric Coulonges; Jay Rappaport; Amu Therwath; Mark Lathrop; Fumihiko MATSUDA; Jean-François Zagury
Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort.
The Journal of infectious diseases 2005;191(2):159-63.
2005: Aicha Abbas; Alexandre Vasilescu; Hervé Do; Houria Hendel; Mustapha Maachi; François-Xavier Goutalier; Emmanuel G Regulier; Jay Rappaport; Fumihiko MATSUDA; Amu Therwath; Pierre Aucouturier; Jean-François Zagury
Analysis of IGG and IGG4 in HIV-1 seropositive patients and correlation with biological and genetic markers.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2005;59(1-2):38-46.
2004: Dianne C Daniel; Yayoi Kinoshita; M Aamir Khan; Luis Del Valle; Kamel Khalili; Jay Rappaport; Edward M Johnson
Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin.
DNA and cell biology 2004;23(12):858-67.
2004: Cheryl A Winkler; Houria Hendel; Mary Carrington; Michael W Smith; George W Nelson; Stephen J O'brien; John Phair; David Vlahov; Lisa P Jacobson; Jay Rappaport; Alexandre Vasilescu; Sebastien Bertin-Maghit; Ping An; Wei Lu; Jean-Marie Andrieu; François Schächter; Amu Therwath; Jean-François Zagury
Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression.
Journal of acquired immune deficiency syndromes (1999) 2004;37(4):1534-8.
2004: Nune Darbinian; Martyn K White; Gary L Gallia; Shohreh Amini; Jay Rappaport; Kamel Khalili
Interaction between the pura and E2F-1 transcription factors.
Anticancer research 2004;24(5A):2585-94.
2004: Tracy Fischer-Smith; Sidney Croul; Aderonke Adeniyi; Katarzyna Rybicka; Susan Morgello; Kamel Khalili; Jay Rappaport
Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy.
The American journal of pathology 2004;164(6):2089-99.
2004: Max W Richardson; Linda Hostalek; Michelle Dobson; Jason Hu; Richard Shippy; Andrew Siwkowski; Jonathan D Marmur; Kamel Khalili; Paul Klotman; Arnold Hampel; Jay Rappaport
Design, targeting, and initial screening of sTRSV-derived hairpin ribozymes for optimum helix 1 length and catalytic efficiency in vitro.
Methods in molecular biology (Clifton, N.J.) 2004;252():339-58.
2004: Max W Richardson; Andrij E Sverstiuk; Peter Silvera; Jack Greenhouse; Julianna Lisziewicz; Franco Lori; Kamel Khalili; Mark G Lewis; Jay Rappaport
T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection.
DNA and cell biology 2004;23(1):1-13.
2004: Emmanuel G Régulier; Krzysztof Reiss; Kamel Khalili; Shohreh Amini; Jean-François Zagury; Peter D Katsikis; Jay Rappaport
T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention.
International reviews of immunology 2004;23(1-2):25-59.
2003: Alexandre Vasilescu; Simon Heath; R Ivanova; Houria Hendel; Hervé Do; A Mazoyer; E Khadivpour; F X Goutalier; Kamel Khalili; Jay Rappaport; G M Lathrop; Fumihiko MATSUDA; Jean-François Zagury
Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression.
Genes and immunity 2003;4(6):441-9.
2003: Max W Richardson; Andrij E Sverstiuk; Edward J Gracely; Houria Hendel; Kamel Khalili; Jean-François Zagury; Jay Rappaport
T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infection.
AIDS (London, England) 2003;17(6):915-7.
2003: Pedro O Flores-Villanueva; Houria Hendel; Sophie Caillat-Zucman; Jay Rappaport; Alberto Burgos-Tiburcio; Sebastien Bertin-Maghit; Jorge A Ruiz-Morales; Maria E Teran; Juan Rodriguez-Tafur; Jean-François Zagury
Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(4):1925-9.
2003: Jin Ying Wang; Francesca Peruzzi; Adam Lassak; Luis Del Valle; Sujahata Radhakrishnan; Jay Rappaport; Kamel Khalili; Shohreh Amini; Krzysztof Reiss
Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia.
Virology 2003;305(1):66-76.
2003: Max W Richardson; Jyotika Mirchandani; Joseph Duong; Sammy Grimaldo; Virginia Kocieda; Houria Hendel; Kamel Khalili; Jean-François Zagury; Jay Rappaport
Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2003;57(1):4-14.
2002: Max W Richardson; Jyotika Mirchandani; Peter Silvera; Emmanuel G Régulier; Christelle Capini; Paul M Bojczuk; Jason Hu; Edward J Gracely; Jean D Boyer; Kamel Khalili; Jean-François Zagury; Mark G Lewis; Jay Rappaport
Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: induction of humoral and cellular immune responses.
DNA and cell biology 2002;21(9):637-51.
2002: Peter Silvera; Max W Richardson; Jack Greenhouse; Jake Yalley-Ogunro; Nigel Shaw; Jyotika Mirchandani; Kamel Khalili; Jean-François Zagury; Mark G Lewis; Jay Rappaport
Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein.
Journal of virology 2002;76(8):3800-9.
2002: Elissa J Schwartz; Avidan U Neumann; Avelino V Teixeira; Leslie A Bruggeman; Jay Rappaport; Alan S Perelson; Paul E Klotman
Effect of target cell availability on HIV-1 production in vitro.
AIDS (London, England) 2002;16(3):341-5.
2001: Tracy Fischer-Smith; Sidney Croul; Andrij E Sverstiuk; Christelle Capini; Darryl Z L'Heureux; Emmanuel G Régulier; Max W Richardson; Shohreh Amini; Susan Morgello; Kamel Khalili; Jay Rappaport
CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.
Journal of neurovirology 2001;7(6):528-41.
2001: Dianne C Daniel; Margaret J Wortman; R J Schiller; H Liu; L Gan; J S Mellen; C F Chang; Gary L Gallia; Jay Rappaport; Kamel Khalili; Edward M Johnson
Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin.
The Journal of general virology 2001;82(Pt 7):1543-53.
2001: Houria Hendel; Cheryl A Winkler; Ping An; E Roemer-Binns; G Nelson; PM Haumont; S O'Brien; K Khalilli; Daniel Zagury; Jay Rappaport; Jean-François Zagury
Validation of genetic case-control studies in AIDS and application to the CX3CR1 polymorphism.
Journal of acquired immune deficiency syndromes (1999) 2001;26(5):507-11.
2001: Christelle Capini; Max W Richardson; Houria Hendel; Andrij E Sverstiuk; Jyotika Mirchandani; Emmanuel G Régulier; Kamel Khalili; Jean-François Zagury; Jay Rappaport
Autoantibodies to TNFalpha in HIV-1 infection: prospects for anti-cytokine vaccine therapy.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2001;55(1):23-31.
2000: L Del Valle; Sidney Croul; Susan Morgello; Shohreh Amini; Jay Rappaport; Kamel Khalili
Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy.
Journal of neurovirology 2000;6(3):221-8.
2000: Bassel E Sawaya; Kamel Khalili; Jennifer Gordon; Alagarsamy Srinivasan; M Richardson; Jay Rappaport; Shohreh Amini
Transdominant activity of human immunodeficiency virus type 1 Vpr with a mutation at residue R73.
Journal of virology 2000;74(10):4877-81.
2000: Max W Richardson; Andrij E Sverstiuk; Houria Hendel; T W Cheung; Jean-François Zagury; Jay Rappaport
Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2000;54(1):21-31.
1999: R Bonwetsch; Sidney Croul; Max W Richardson; C Lorenzana; L Del Valle; Andrij E Sverstiuk; Shohreh Amini; Susan Morgello; Kamel Khalili; Jay Rappaport
Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders.
Journal of neurovirology 1999;5(6):685-94.
1999: Gary L Gallia; Nune Darbinian; Anna Tretiakova; SA Ansari; Jay Rappaport; J Brady; Margaret J Wortman; Edward M Johnson; Kamel Khalili
Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(20):11572-7.
1999: Y Lian; M B De Young; Andrew Siwkowski; Arnold Hampel; Jay Rappaport
The sCYMV1 hairpin ribozyme: targeting rules and cleavage of heterologous RNA.
Gene therapy 1999;6(6):1114-9.
1999: Houria Hendel; Sophie Caillat-Zucman; H Lebuanec; Mary Carrington; S O'Brien; Jean-Marie Andrieu; François Schächter; Daniel Zagury; Jay Rappaport; Cheryl A Winkler; George W Nelson; Jean-François Zagury
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(11):6942-6.
1999: Bassel E Sawaya; Kamel Khalili; Jay Rappaport; D Serio; W Chen; A Srinivasan; Shohreh Amini
Suppression of HIV-1 transcription and replication by a Vpr mutant.
Gene therapy 1999;6(5):947-50.
1999: Jay Rappaport; J Joseph; Sidney Croul; G Alexander; Luis Del Valle; Shohreh Amini; Kamel Khalili
Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.
Journal of leukocyte biology 1999;65(4):458-65.
1999: Alessandro Gringeri; Elena Santagostino; Myrvet Muça-Perja; Hélène Le Buanec; Bernard Bizzini; Abderrahim LACHGAR; Jean-François Zagury; Jay Rappaport; Arsène Burny; Robert C Gallo; Daniel Zagury
Tat toxoid as a component of a preventive vaccine in seronegative subjects.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(4):371-5.
1999: M Kundu; SA Ansari; L G Chepenik; R J Pomerantz; Kamel Khalili; Jay Rappaport; Shohreh Amini
HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Journal of human virology 1999;2(2):72-80.
1998: Houria Hendel; N Hénon; H Lebuanec; Abderrahim LACHGAR; H Poncelet; Sophie Caillat-Zucman; Cheryl A Winkler; Michael W Smith; L Kenefic; S O'Brien; W Lu; Jean-Marie Andrieu; Daniel Zagury; François Schächter; Jay Rappaport; Jean-François Zagury
Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(4):381-6.
1998: Alessandro Gringeri; Elena Santagostino; Myrvet Muça-Perja; Pier M Mannucci; Jean-François Zagury; Bernard Bizzini; Abderrahim LACHGAR; M Carcagno; Jay Rappaport; M Criscuolo; William A Blattner; Arsène Burny; Robert C Gallo; Daniel Zagury
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients.
Journal of human virology 1998;1(4):293-8.
1998: Jean-François Zagury; Anne M Sill; William A Blattner; Abderrahim LACHGAR; Hélène Le Buanec; M Richardson; Jay Rappaport; Houria Hendel; Bernard Bizzini; Alessandro Gringeri; M Carcagno; M Criscuolo; Arsène Burny; Robert C Gallo; Daniel Zagury
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
Journal of human virology 1998;1(4):282-92.
1998: Daniel Zagury; Abderrahim LACHGAR; VIDA CHAMS; L S Fall; J Bernard; Jean-François Zagury; Bernard Bizzini; Alessandro Gringeri; Elena Santagostino; Jay Rappaport; M Feldman; S J O'Brien; Arsène Burny; Robert C Gallo
C-C chemokines, pivotal in protection against HIV type 1 infection.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3857-61.
1998: Daniel Zagury; Abderrahim LACHGAR; VIDA CHAMS; L S Fall; J Bernard; Jean-François Zagury; Bernard Bizzini; Alessandro Gringeri; Elena Santagostino; Jay Rappaport; M Feldman; Arsène Burny; Robert C Gallo
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3851-6.
1998: Abderrahim LACHGAR; G Jaureguiberry; H Le Buenac; Bernard Bizzini; Jean-François Zagury; Jay Rappaport; Daniel Zagury
Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC).
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1998;52(10):436-9.
1998: Hélène Le Buanec; Abderrahim LACHGAR; Bernard Bizzini; Jean-François Zagury; Jay Rappaport; Elena Santagostino; Myrvet Muça-Perja; Alessandro Gringeri
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoid.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1998;52(10):431-5.
1998: Gabriele Baier-Bitterlich; Anna Tretiakova; Max W Richardson; Kamel Khalili; Bradford Jameson; Jay Rappaport
Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1998;52(10):421-30.
1997: Jay Rappaport; Y Y Cho; Houria Hendel; Elissa J Schwartz; F Schachter; Jean-François Zagury
32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.
Lancet 1997;349(9056):922-3.
1997: Y Y Cho; A Astgen; Houria Hendel; Wolfgang J Issing; J Y Perrot; F Schachter; Jay Rappaport; Jean-François Zagury
Homeostasis of chemokines, interferon production and lymphocyte subsets: implications for AIDS pathogenesis.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1997;51(5):221-9.
1996: Houria Hendel; Y Y Cho; N Gauthier; Jay Rappaport; François Schächter; Jean-François Zagury
Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1996;50(10):480-7.
1995: Jay Rappaport; S K Arya; Max W Richardson; Gabriele Baier-Bitterlich; Paul E Klotman
Inhibition of HIV-1 expression by HIV-2.
Journal of molecular medicine (Berlin, Germany) 1995;73(12):583-9.
1992: M Chowdhury; J. Paul Taylor; C F Chang; Jay Rappaport; Kamel Khalili
Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
Journal of virology 1992;66(12):7355-61.
1992: J. Paul Taylor; R Pomerantz; Omar Bagasra; M Chowdhury; Jay Rappaport; Kamel Khalili; Shohreh Amini
TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.
The EMBO journal 1992;11(9):3395-403.
1990: M Chowdhury; J. Paul Taylor; H Tada; Jay Rappaport; F Wong-Staal; Shohreh Amini; Kamel Khalili
Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.
Oncogene 1990;5(12):1737-42.
1990: S Ahmed; Jay Rappaport; H Tada; D Kerr; Kamel Khalili
A nuclear protein derived from brain cells stimulates transcription of the human neurotropic virus promoter, JCVE, in vitro.
The Journal of biological chemistry 1990;265(23):13899-905.
1990: H Tada; Jay Rappaport; M Lashgari; Shohreh Amini; F Wong-Staal; Kamel Khalili
Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(9):3479-83.
1989: H Tada; M Lashgari; Jay Rappaport; Kamel Khalili
Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation.
Journal of virology 1989;63(1):463-6.